Home

  • Order to parcel locker

    Order to parcel locker

  • easy pay

    easy pay
  • Reduced price
Manual of Hematopoietic Cell Transplantation and Cellular Therapies

Manual of Hematopoietic Cell Transplantation and Cellular Therapies

9780323798334
1,159.15 zł
985.28 zł Save 173.87 zł Tax included
Lowest price within 30 days before promotion: 985.28 zł
Quantity
Available in 4-6 weeks

  Delivery policy

Choose Paczkomat Inpost, Orlen Paczka, DPD or Poczta Polska. Click for more details

  Security policy

Pay with a quick bank transfer, payment card or cash on delivery. Click for more details

  Return policy

If you are a consumer, you can return the goods within 14 days. Click for more details

Description
Led by authors from MD Andersons Stem Cell Transplantation and Cellular Therapy Department, the worlds largest and highly respected program at the forefront of rapidly advancing treatments in the field, Manual of Hematopoietic Cell Transplantation and Cellular Therapies is a comprehensive, focused reference covering the latest clinical developments and applications of stem cell transplant and cellular therapies for hematologic malignancies and solid tumors. This cutting-edge title, with a majority contribution from the MD Anderson Cancer Center and leading faculty from other academic institutions, covers breakthrough cell-based therapies for various diseases including lymphoma, multiple myeloma, leukemia, and select solid tumor and autoimmune diseases. This unique, definitive resource is essential for hematologists, fellows in hematology and immunotherapy, mid-level providers, pharmacists, and oncologists who refer patients for cell-based therapies.
Product Details
Elsevier
94102
9780323798334
9780323798334

Data sheet

Publication date
2023
Issue number
1
Cover
hard cover
Pages count
608
Dimensions (mm)
216 x 276
Weight (g)
1460

  • Part One Introduction

    Ch 1 Evolution of HCT, past, present, and future

    Ch 2 Human leukocyte antigen

    Ch 3 Introduction and basic science of chimeric antigen receptor therapies

    Ch 4 Statistical methods in HCT and cellular therapies

    Part Two Methodology

    Ch 5 Hematopoietic cell collection; bone marrow harvesting, apheresis, UCB

    Ch 6 Leukapheresis and manufacturing of CAR cells

    Part Three General Clinical Aspects

    Ch 7 Patient and donor selection and preparing for HCT

    Ch 8 General management of patients undergoing HCT

    Ch 9 Haploidentical HCT

    Ch 10 Umbilical cord blood transplantation

    Ch 11 Process and general management of patients undergoing CAR therapies

    Part Four Pharmacology and Radiation Therapy

    Ch 12 Preparative regimens used in HCT and CAR therapies

    Ch 13 Pharmacology of drugs used in HCT and CAR therapies

    Ch 14 Role of radiation therapy in HCT and CAR therapies

    Part Five Disease-Specific Indications and Results

    Ch 15 HCT in AML

    Ch 16 CAR therapy in AML

    Ch 17 HCT in ALL

    Ch 18 CAR therapy in ALL

    Ch 19 HCT in chronic leukemias; CML and CLL

    Ch 20 HCT in MDS

    Ch 21 HCT in myeloproliferative disorders

    Ch 22 HCT in aplastic anemia

    Ch 23 HCT in multiple myeloma

    Ch 24 CAR therapy in multiple myeloma

    Ch 25 HCT in light-chain amyloidosis

    Ch 26 HCT in NHL

    Ch 27 HCT in Hodgkin lymphoma

    Ch 28 CAR therapy in lymphoma

    Ch 29 HCT in rare malignancies

    Ch 30 HCT for hematologic malignancies in HIV patients

    Ch 31 HCT in solid tumors

    Part Six Prevention and Management of Complications

    Ch 32 Infectious complications

    Ch 33 Graft failure

    Ch 34 Graft-versus-host disease

    Ch 35 Miscellaneous complications of HCT

    Ch 36 Cytokine release syndrome

    Ch 37 Neurologic complications of CAR therapy (ICANS)

    Ch 38 Miscellaneous complications of CAR therapy

    Ch 39 Symptoms management and palliative care

    Ch 40 Survivorship

Comments (0)

  • Frequently purchased together

    No products available